Send feedback

TP53 p.Arg335=

c.1005T>G · rs2150995287 · VCV1086350

Likely benign Single submitter
Classification
Likely benign
ClinVar
Review
Single submitter ★☆☆☆
ClinVar · 1 submitter
gnomAD v4.1
Rare
very rare (popmax 0.00331%, nfe)
Conditions
1
Li-Fraumeni syndrome

Computational evidence

Protein change
Missense predictors do not apply to this variant type; conservation carries the signal.
Splicing
SpliceAI—not assessed · no allele here is in the release
Constraint at this position
ConservationphyloP 0.13GERP -4
Overall
CADD5.608PHRED · no single calibrated threshold — expert panels disagree

Population frequency

gnomAD v4.1 · exomes + genomes
Grpmax group 0.00331% European (non-Finnish) · 39/1,179,318 alleles
Filtering AF 0.00248% ClinGen BA1/BS1 input FAF95, joint · FAF99 0.00217%
Overall 0.00267% 43/1,613,274 alleles · very rare exomes 43/1,461,012 · genomes 0/152,262 · joint denominator
Ancestry group Frequency 1 in
Ashkenazi Jewishnot grpmax-eligible 0.00338% 29,590
European (non-Finnish)grpmax 0.00331% 30,239
African / African-American 0.00267% 37,513
Remaining individualsnot grpmax-eligible 0.0016% 62,468

Ashkenazi Jewish shows a higher raw frequency than the grpmax group above it. gnomAD excludes bottlenecked groups — Finnish, Ashkenazi Jewish, Amish and “Remaining individuals” — from grpmax, because founder effects make their frequencies unrepresentative for filtering. The table is sorted by frequency, so an excluded group can sit above the grpmax row.

Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.

Variant & gene context

Gene
TP53
Protein
p.Arg335=
Coding
c.1005T>G
MANE Select
NM_000546
dbSNP
rs2150995287
Type
single nucleotide variant
Location
chr17:7670704 (GRCh38)
Gene constraint
LOEUF 0.449 · pLI 1.00 · ClinGen HI 3/3 (gnomAD)
Structure
AlphaFold pLDDT 75.83 · 321 PDB
Residue 335
a UniProt-annotated variant site (in a sporadic cancer; somatic mutation); the 'interaction with carm1' region; an α-helix; the 'interaction with hipk2' region; the 'oligomerization' region; a modified residue (symmetric dimethylarginine; by prmt5); the 'interaction with hipk1' region
Full TP53 gene report on Sugi Atlas → Gene function, pathways, protein structure, interactions & more

Disease context

Li-Fraumeni syndrome — disease report on Sugi Atlas → Associated genes, phenotypes, clinical trials & treatments

For Li-Fraumeni syndrome (Orphanet):

Inheritance
Autosomal dominant
Onset
All ages
Prevalence
1-9 / 100 000 (United Kingdom)

Similar variants

Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →

Cite Sugi Variant

Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/tp53-p-arg335 (accessed [today's date]).

Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown